Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in advanced thyroid cancer
NCT01728623Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2012
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 2 trial of lenvatinib in thyroid cancer, sponsored by Eisai Co., Ltd.. Started Sep 2012; status: completed.
02
Drugs
lenvatinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT01728623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728623.